Lakhal, Karim http://orcid.org/0000-0002-5311-3987
Robert-Edan, Vincent
Rodie-Talbere, Pierre-André
Ambrosi, Xavier
Fresco, Marion
Article History
Received: 28 October 2021
Accepted: 29 October 2021
First Online: 23 November 2021
Conflict of interest
: Karim Lakhal has no conflict of interest in connection with the work submitted. In addition, KL received, during the past 3 years, congress registration fees from Sanofi Aventis (once in 2018) and travel fees from MSD France (once in 2017), Gilead Sciences (once in 2017), Pfizer (three times, in 2019, 2020, and 2021), and Advanz Pharma (twice in 2020 and once in 2021). Vincent Robert-Edan has no conflict of interest in connection with the work submitted. In addition, VRE received, during the past 3 years, travel fees from Pfizer (once in 2020). None of the other authors have any financial or nonfinancial competing interests in connection with this study.